calendar
2,339 catalysts · 4,590 phase readout · 2,336 8k filing · 285 earnings · 172 phase 2 completion · 162 pdufa · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
2,339 catalysts · 4,590 phase readout · 2,336 8k filing · 285 earnings · 172 phase 2 completion · 162 pdufa · 73 phase 1 completion
no tagged catalysts yet
Items: 8.01, 9.01
Items: 8.01
Items: 8.01
Items: 8.01
Items: 5.02
Items: 7.01, 9.01
Items: 5.02, 9.01
Items: 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 1.01, 3.03, 5.03, 7.01, 9.01
Items: 5.07
Items: 1.01, 7.01, 9.01
Items: 1.01, 9.01
Items: 7.01, 9.01
Items: 8.01
Items: 1.03, 3.01
Items: 8.01
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 5.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 8.01, 9.01
Items: 5.07
Items: 5.02
Items: 1.01, 3.02, 9.01
Items: 5.07
Items: 5.03, 5.07, 9.01
Items: 3.01
Items: 8.01, 9.01
Items: 5.02
Items: 5.07, 9.01
Items: 8.01, 9.01
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL